Compare Ecopetrol SA (EC) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs Summit Therapeutics Inc — how do they compare? Ecopetrol SA trades at $17.01 (market cap $33.69B), while Summit Therapeutics Inc trades at $15.6 (market cap $12.06B). The key difference: Ecopetrol SA is far larger — about 2.8× Summit Therapeutics Inc's market cap, and Ecopetrol SA pays a 3.82% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| EC | SMMT | |
|---|---|---|
Market Cap | $33.69B | $12.06B |
Sector | Energy | Health |
52-Week High | $17.40 | $26.98 |
52-Week Low | $8.56 | $12.55 |
Enterprise Value | $63.86B | $11.39B |
Dividend Yield | 3.82% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
